Literature DB >> 300328

Effects of several 'membrane stabilizing' agents on frog neuromuscular junction.

S D Boucher, N L Katz.   

Abstract

The effect of several "membrane stabilizing" agents was examined on spontaneously occurring frog miniature end-plate potentials (MEPPs). No consistent parallel was observed between the ability of agents to act as "membrane stabilizers" and their ability to alter MEPP frequency, Vinblastine, chlorpromazine and haloperidol increased MEPP frequency; the concentration of haloperidol which increased MEPP frequency consistently reduced the magnitude of the muscle resting membrane potential. Strychnine, methoxyflurane and practolol decreased MEPP frequency. Similarly, there was no consistent pattern of drug effects on the mean quantal content m of the end-plate potential. Chlorpromazine did not change m, and it is known that vinblastine does not influence m. Strychnine, methoxyflurane, haloperidol and practolol brought about a decline in m.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300328     DOI: 10.1016/0014-2999(77)90353-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Postsynaptic inhibitory effects of phenothiazines at cholinergic synapses may not involve calmodulin.

Authors:  Z Y Sahaf; S J Publicover
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

2.  Lidocaine treatment during synapse reformation periods permanently inhibits NGF-induced excitation in an identified reconstructed synapse of Lymnaea stagnalis.

Authors:  Shin Onizuka; Seiji Shiraishi; Ryuuji Tamura; Tetsu Yonaha; Nobuko Oda; Yuko Kawasaki; Naweed I Syed; Tetsuro Shirasaka; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2011-10-30       Impact factor: 2.078

3.  Acute and chronic effects of clozapine on cholinergic transmission in cultured mouse superior cervical ganglion neurons.

Authors:  Taixiang Saur; Bruce M Cohen; Qi Ma; Suzann M Babb; Edgar A Buttner; Wei-Dong Yao
Journal:  J Neurogenet       Date:  2016-09-14       Impact factor: 1.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.